Pleural Neoplasms

Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms.

Also Known As:

Networked: 24 relevant articles (0 outcomes, 6 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Lung Neoplasms (Lung Cancer)
2.	Mesothelioma
3.	Neoplasms (Cancer)
4.	Small Cell Carcinoma

Experts

1.	Comba, Pietro: 4 articles (01/2012 - 03/2003)
2.	Zona, Amerigo: 2 articles (01/2012 - 01/2011)
3.	Marinaccio, Alessandro: 2 articles (01/2012 - 01/2011)
4.	Binazzi, Alessandra: 2 articles (01/2011 - 03/2003)
5.	Belli, Stefano: 2 articles (01/2011 - 03/2003)
6.	Paoletti, Luigi: 2 articles (06/2004 - 10/2003)
7.	Bruni, Biagio: 2 articles (06/2004 - 10/2003)
8.	Trinca, Stefania: 2 articles (05/2004 - 03/2003)
9.	Mastrantonio, Marina: 2 articles (05/2004 - 03/2003)
10.	Bruno, Caterina: 1 article (01/2012)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Pleural Neoplasms:

1.	AsbestosIBA 01/01/2012 - "The present study confirms malignant pleural neoplasms mortality as a suitable indicator of asbestos exposure at geographic level. " 01/01/2012 - "In addition to asbestos-cement industries and shipyards, other industrial settings are associated with pleural neoplasm mortality." 01/01/2012 - "Mortality from malignant pleural neoplasms in Italy was analyzed, to estimate the health impact of asbestos at national and local level. " 09/01/2011 - "Asbestos and pleural neoplasm represent an unique case. " 05/01/2004 - "The purpose of the present paper is to describe the geographical distribution at municipality level of mortality from malignant pleural neoplasms in the Campania Region, along with the distribution of former asbestos-exposed workers. "
2.	P-GlycoproteinIBA 01/01/1989 - "In this study, 212 untreated primary pulmonary and pleural neoplasms were studied immunohistochemically with the monoclonal antibody HYB-612 which detects the multidrug resistance (MDR)-related P-glycoprotein (gp180). "
3.	SteamIBA 09/01/2005 - "The excess of pleural neoplasms reported in this study suggests the opportunity to evaluate the risk due to asbestos use in many manifacturing industries, especially where steam was used for extractive or warming purpose."
4.	Cisplatin (Platino)FDA LinkGeneric 06/01/2002 - "Malignant pleural mesothelioma (MPM) is a highly lethal pleural neoplasm that is often resistant to chemotherapeutic drugs, including cisplatin, and for which little is known regarding carcinogenic pathways. " 07/01/1990 - "[Cisplatin and cytosine arabinoside (ARA-C) for the therapy of primary and secondary pleural neoplasms]."
5.	AmylasesFDA Link 07/01/1996 - "During a pathologic evaluation of pleural neoplasms between 1975 and 1990, 10 epithelial mesotheliomas were identified that were mucicarmine- and in some instances PAS-diastase-positive (diagnosis of mesothelioma confirmed by ultrastructural examination), with four mesotheliomas focally expressing carcinoembryonic antigen. " 01/01/1994 - "Our investigation shows that a battery of several tumor markers, such as antibodies against LeuM1, CEA, and the antibody BerEP4, as well as staining with periodic acid/Schiff/diastase discriminate primary from secondary pleural neoplasms, whilst intermediate filament proteins alone are of little diagnostic value."
6.	Biological Tumor Markers (Tumor Markers)IBA 01/01/1994 - "Our investigation shows that a battery of several tumor markers, such as antibodies against LeuM1, CEA, and the antibody BerEP4, as well as staining with periodic acid/Schiff/diastase discriminate primary from secondary pleural neoplasms, whilst intermediate filament proteins alone are of little diagnostic value."
7.	TriaziquoneIBA 01/01/1965 - "[Clinical observations on treatment with "Trenimon" of pulmonary and pleural neoplasms]."
8.	Periodic AcidIBA 01/01/1994 - "Our investigation shows that a battery of several tumor markers, such as antibodies against LeuM1, CEA, and the antibody BerEP4, as well as staining with periodic acid/Schiff/diastase discriminate primary from secondary pleural neoplasms, whilst intermediate filament proteins alone are of little diagnostic value."
9.	Intermediate Filament ProteinsIBA 01/01/1994 - "Our investigation shows that a battery of several tumor markers, such as antibodies against LeuM1, CEA, and the antibody BerEP4, as well as staining with periodic acid/Schiff/diastase discriminate primary from secondary pleural neoplasms, whilst intermediate filament proteins alone are of little diagnostic value."
10.	Cytarabine (Cytosar-U)FDA LinkGeneric 07/01/1990 - "[Cisplatin and cytosine arabinoside (ARA-C) for the therapy of primary and secondary pleural neoplasms]."